Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress

Benedetta Porro, Sonia Eligini, Fabrizio Veglia, Alessandro Lualdi, Isabella Squellerio, Susanna Fiorelli, Marta Giovannardi, Elisa Chiorino, Alessia Dalla Cia, Mauro Crisci, José Pablo Werba, Elena Tremoli, Viviana Cavalca

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A decreased nitric oxide (NO) bioavailability and an increased oxidative stress play a pivotal role in different cardiovascular pathologies. As red blood cells (RBCs) participate in NO formation in the bloodstream, the aim of this study was to outline the metabolic profile of L-arginine (Arg)/NO pathway and of oxidative stress status in RBCs and in plasma of patients with microvascular angina (MVA), investigating similarities and differences with respect to coronary artery disease (CAD) patients or healthy controls (Ctrl). Analytes involved in Arg/NO pathway and the ratio of oxidized and reduced forms of glutathione were measured by LC-MS/MS. The arginase and the NO synthase (NOS) expression were evaluated by immunofluorescence staining. RBCs from MVA patients show increased levels of NO synthesis inhibitors, parallel to that found in plasma, and a reduction of NO synthase expression. When summary scores were computed, both patient groups were associated with a positive oxidative score and a negative NO score, with the CAD group located in a more extreme position with respect to Ctrl. This finding points out to an impairment of the capacity of RBCs to produce NO in a pathological condition characterized mostly by alterations at the microvascular bed with no significant coronary stenosis.

Original languageEnglish
Article number726539
JournalOxidative Medicine and Cellular Longevity
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Microvascular Angina
Oxidative stress
Nitric Oxide
Oxidative Stress
Blood
Erythrocytes
Nitric Oxide Synthase
Coronary Artery Disease
Plasmas
Arginase
Metabolome
Coronary Stenosis
Pathology
Biological Availability
Fluorescent Antibody Technique
Glutathione
Arginine
Cells
Staining and Labeling

ASJC Scopus subject areas

  • Cell Biology
  • Ageing
  • Biochemistry
  • Medicine(all)

Cite this

@article{a0473fc7fcb54da99192373296243ec2,
title = "Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress",
abstract = "A decreased nitric oxide (NO) bioavailability and an increased oxidative stress play a pivotal role in different cardiovascular pathologies. As red blood cells (RBCs) participate in NO formation in the bloodstream, the aim of this study was to outline the metabolic profile of L-arginine (Arg)/NO pathway and of oxidative stress status in RBCs and in plasma of patients with microvascular angina (MVA), investigating similarities and differences with respect to coronary artery disease (CAD) patients or healthy controls (Ctrl). Analytes involved in Arg/NO pathway and the ratio of oxidized and reduced forms of glutathione were measured by LC-MS/MS. The arginase and the NO synthase (NOS) expression were evaluated by immunofluorescence staining. RBCs from MVA patients show increased levels of NO synthesis inhibitors, parallel to that found in plasma, and a reduction of NO synthase expression. When summary scores were computed, both patient groups were associated with a positive oxidative score and a negative NO score, with the CAD group located in a more extreme position with respect to Ctrl. This finding points out to an impairment of the capacity of RBCs to produce NO in a pathological condition characterized mostly by alterations at the microvascular bed with no significant coronary stenosis.",
author = "Benedetta Porro and Sonia Eligini and Fabrizio Veglia and Alessandro Lualdi and Isabella Squellerio and Susanna Fiorelli and Marta Giovannardi and Elisa Chiorino and {Dalla Cia}, Alessia and Mauro Crisci and Werba, {Jos{\'e} Pablo} and Elena Tremoli and Viviana Cavalca",
year = "2014",
doi = "10.1155/2014/726539",
language = "English",
volume = "2014",
journal = "Oxidative Medicine and Cellular Longevity",
issn = "1942-0900",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress

AU - Porro, Benedetta

AU - Eligini, Sonia

AU - Veglia, Fabrizio

AU - Lualdi, Alessandro

AU - Squellerio, Isabella

AU - Fiorelli, Susanna

AU - Giovannardi, Marta

AU - Chiorino, Elisa

AU - Dalla Cia, Alessia

AU - Crisci, Mauro

AU - Werba, José Pablo

AU - Tremoli, Elena

AU - Cavalca, Viviana

PY - 2014

Y1 - 2014

N2 - A decreased nitric oxide (NO) bioavailability and an increased oxidative stress play a pivotal role in different cardiovascular pathologies. As red blood cells (RBCs) participate in NO formation in the bloodstream, the aim of this study was to outline the metabolic profile of L-arginine (Arg)/NO pathway and of oxidative stress status in RBCs and in plasma of patients with microvascular angina (MVA), investigating similarities and differences with respect to coronary artery disease (CAD) patients or healthy controls (Ctrl). Analytes involved in Arg/NO pathway and the ratio of oxidized and reduced forms of glutathione were measured by LC-MS/MS. The arginase and the NO synthase (NOS) expression were evaluated by immunofluorescence staining. RBCs from MVA patients show increased levels of NO synthesis inhibitors, parallel to that found in plasma, and a reduction of NO synthase expression. When summary scores were computed, both patient groups were associated with a positive oxidative score and a negative NO score, with the CAD group located in a more extreme position with respect to Ctrl. This finding points out to an impairment of the capacity of RBCs to produce NO in a pathological condition characterized mostly by alterations at the microvascular bed with no significant coronary stenosis.

AB - A decreased nitric oxide (NO) bioavailability and an increased oxidative stress play a pivotal role in different cardiovascular pathologies. As red blood cells (RBCs) participate in NO formation in the bloodstream, the aim of this study was to outline the metabolic profile of L-arginine (Arg)/NO pathway and of oxidative stress status in RBCs and in plasma of patients with microvascular angina (MVA), investigating similarities and differences with respect to coronary artery disease (CAD) patients or healthy controls (Ctrl). Analytes involved in Arg/NO pathway and the ratio of oxidized and reduced forms of glutathione were measured by LC-MS/MS. The arginase and the NO synthase (NOS) expression were evaluated by immunofluorescence staining. RBCs from MVA patients show increased levels of NO synthesis inhibitors, parallel to that found in plasma, and a reduction of NO synthase expression. When summary scores were computed, both patient groups were associated with a positive oxidative score and a negative NO score, with the CAD group located in a more extreme position with respect to Ctrl. This finding points out to an impairment of the capacity of RBCs to produce NO in a pathological condition characterized mostly by alterations at the microvascular bed with no significant coronary stenosis.

UR - http://www.scopus.com/inward/record.url?scp=84901299648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901299648&partnerID=8YFLogxK

U2 - 10.1155/2014/726539

DO - 10.1155/2014/726539

M3 - Article

VL - 2014

JO - Oxidative Medicine and Cellular Longevity

JF - Oxidative Medicine and Cellular Longevity

SN - 1942-0900

M1 - 726539

ER -